Personalizing Nutrition and Health
The emerging field of nutrigenomics offers the potential to deliver appropriate foods to individuals based on their personal health needs. Session 212 “Nutrigenomics, nutritional phenotype, and delivery of personalized nutrition” on Tuesday morning, July 20, at 8:30–10 a.m. in Room S401cd will feature experts from the U.S. FDA Office of Personalized Nutrition and the European Union Nutrigenomics Organization, who will lead attendees toward an understanding of the genomic, proteomic, metabolomic, and nutritional status assessment technologies used to determine individual nutritional phenotypes, as well as the technical and regulatory opportunities and challenges facing the development and delivery of publicly available online knowledge repositories about nutritional phenotypes and their appropriate nutritional interventions.
Ben van Ommen, TNO Quality of Life, will provide background and the mission of the EU Nutrigenomics Organization, the science behind the concept of a nutritional phenotype, and its recent efforts with the FDA to produce internationally agreed upon standards for a nutritional phenotype database.
Jim Kaput, FDA, will discuss research strategies for personalizing nutrition, medicine, and health care. To reach the goal of personalizing medicine and nutrition, new experimental strategies are needed for human study designs. A promising approach for more complete analyses of the interaction of genetic make-ups and environment relies on the translational research concept of community-based participatory research (CBPR). Successful development of these strategies and research studies require national and international cooperation.
